[Use of vepeside in mono- and polychemotherapy of various malignant neoplasms].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D005047:Etoposide; D011034:Podophyllotoxin
Zastosowanie vepesidu w mono- i polichemioterapii niektórych nowotworów złośliwych.